The present invention mainly addresses the problem of providing a novel combination therapy that exhibits remarkable antitumor effect.Provided, as a means for solving the above-mentioned problem, is an antitumor agent which comprises a combination of oxaliplatin, paclitaxel and a combined agent that contains tegafur, gimeracil and oteracil potassium.